Corpus Intelligence IC Memo — REHABILITATION HOSPITAL OF WISCONSIN 2026-04-26 15:02 UTC
IC Memo — REHABILITATION HOSPITAL OF WISCONSIN
Investment Committee Memorandum | WI | 40 beds | Grade C | EBITDA uplift $1.8M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

REHABILITATION HOSPITAL OF WISCONSIN

CCN 523027 | WAUKESHA, WI | 40 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

REHABILITATION HOSPITAL OF WISCONSIN is a 40-bed suburban community hospital in WAUKESHA, WI with $24.9M in net patient revenue and a 33.1% operating margin. The hospital serves a payer mix of 56.4% Medicare, 0.1% Medicaid, and 43.5% commercial.

Thesis: Turnaround. Our ML models identify $1.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 33.1% to 40.4% (+736bps).

Net Revenue HCRIS$24.9M
Current EBITDA COMPUTED$8.2M
Operating Margin COMPUTED33.1%
Occupancy HCRIS83.0%
Revenue / Bed COMPUTED$621K
Net-to-Gross HCRIS68.3%
Distress Probability ML45.6%

2. Market Context & Competitive Position

150
WI Hospitals
0.4%
State Median Margin
89
Comparable Hospitals

WI has 150 Medicare-certified hospitals with a median operating margin of 0.4%. The target's margin of 33.1% places it above the state median. Among 89 size-comparable peers (20-80 beds), the median margin is 1.6%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (20-80), prioritizing same-state peers. 89 hospitals in the comp set.

HospitalStateBedsRevenueMargin
REHABILITATION HOSPITAL OF WIS (Target)WI40$24.9M33.1%
MERCY WALWORTH HOSPITALWI25$616.4M4.4%
ST. JOSEPHS COMM. HOSPT.WI70$436.8M66.1%
ST. AGNES HOSPITALWI77$275.9M-3.0%
AURORA MEDICAL CENTER OF OSHKOWI79$222.3M17.9%
MARSHFIELD MEDICAL CENTER-EAU WI56$214.6M-21.8%
MONROE CLINICWI58$195.3M-4.4%
ASPIRUS RIVERVIEW HOSPITAL & CWI44$161.3M13.1%
MEMORIAL MEDICAL CENTER INC.WI25$138.4M8.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.8M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$522K+210bp18mo
Cost to Collect4.5%2.5%$497K+200bp12mo
Denial Rate Reduction12.0%6.5%$492K+198bp12mo
A/R Days Reduction5200.0%3800.0%$302K+122bp9mo
Clean Claim Rate88.0%96.0%$16K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$522K
Cost to Collect
$497K
Denial Rate Reduction
$492K
A/R Days Reduction
$302K
Clean Claim Rate
$16K
Total EBITDA Uplift$1.8M
Current EBITDA$8.2M
+ RCM Uplift+$1.8M
Pro Forma EBITDA$10.0M
Current Margin33.1%
Pro Forma Margin40.4%
WC Released (1x)$953K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$12.6M$72.5M5.73x41.8%
Base (11x exit)10.0x11.0x$12.6M$83.9M6.63x46.0%
Bull Case9.0x11.0x$11.4M$94.0M8.26x52.5%
Bull (12x exit)9.0x12.0x$11.4M$105.9M9.31x56.2%
Bear Case11.0x10.0x$13.9M$59.3M4.26x33.6%
Bear (11x exit)11.0x11.0x$13.9M$69.7M5.01x38.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 56.4% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 89 hospitals with 20-80 beds
  • Same-state prioritization (n=90)
  • Comp margins: P25=-8.4% / P50=1.6% / P75=8.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.